Cargando…
Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy
Today, HIV-infected (HIV(+)) patients can be treated efficiently with combined antiretroviral therapy (cART), leading to long-term suppression of viral load, in turn increasing life expectancy. While cART reduced the occurrence of HIV-associated dementia, the prevalence of subtle forms of HIV-associ...
Autores principales: | Ambrosius, Björn, Gold, Ralf, Chan, Andrew, Faissner, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501636/ https://www.ncbi.nlm.nih.gov/pubmed/31119186 http://dx.doi.org/10.1212/NXI.0000000000000551 |
Ejemplares similares
-
Neuroimaging of HIV-associated neurocognitive
disorders
por: Haziot, Michel Elyas Jung, et al.
Publicado: (2015) -
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
por: Ambrosius, Björn, et al.
Publicado: (2017) -
The impacts of visual Art Therapy for elderly with Neurocognitive disorder: a systematic review
por: de Souza, Leonardo Brynne Ramos, et al.
Publicado: (2022) -
The Antineuroinflammatory Effect of Simvastatin on Lipopolysaccharide Activated Microglial Cells
por: Zheng, Xinrui, et al.
Publicado: (2018) -
Adjuvant therapies for HIV-associated neurocognitive disorders
por: McGuire, Jennifer L, et al.
Publicado: (2014)